“Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: 3-Year Results from the ALLEGRO-LT Phase 3, Open-Label Study”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 4, July 2025, p. s582, https://doi.org/10.25251/gdd40x24.